{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:59:23Z","timestamp":1793383163011,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1114766"],"award-info":[{"award-number":["OPP1114766"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.vaccine.2022.06.034","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T08:00:04Z","timestamp":1655452804000},"page":"4361-4370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries"],"prefix":"10.1016","volume":"40","author":[{"given":"Jessica E.","family":"Atwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea S.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin G.","family":"Sparrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5154-5084","authenticated-orcid":false,"given":"Daniel R.","family":"Feikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.06.034_b0005","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.06.034_b0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.inf.0000069768.34383.18","article-title":"Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants","volume":"22","author":"Singleton","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.034_b0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","year":"2014","journal-title":"Pediatrics"},{"issue":"140","key":"10.1016\/j.vaccine.2022.06.034_b0020","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"1986","author":"Glezen","year":"1960","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.vaccine.2022.06.034_b0025","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group","volume":"329","author":"Groothuis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.06.034_b0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1128\/CMR.8.1.22","article-title":"Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections","volume":"8","author":"Hemming","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2022.06.034_b0035","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/infdis\/169.6.1368","article-title":"Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin","volume":"169","author":"Siber","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/INF.0b013e31815ac585","article-title":"The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease","volume":"27","author":"Eick","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2022.06.034_b0045","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1016\/j.vaccine.2016.07.057","article-title":"Challenges and opportunities in RSV vaccine development: meeting report from FDA\/NIH workshop","volume":"34","author":"Roberts","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.034_b0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/QCO.0000000000000161","article-title":"Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?","volume":"28","author":"Munoz","year":"2015","journal-title":"Curr Opin Infect Diseases"},{"key":"10.1016\/j.vaccine.2022.06.034_b0055","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/S1473-3099(16)00119-5","article-title":"Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?","volume":"16","author":"Saso","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0060","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S1473-3099(18)30292-5","article-title":"The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates","volume":"18","author":"Mazur","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0065","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1016\/j.vaccine.2016.03.109","article-title":"Advances in RSV vaccine research and development - A global agenda","volume":"34","author":"Higgins","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.034_b0070","unstructured":"PATH. RSV Vaccine and mAb Snapshot. https:\/\/www.path.org\/resources\/rsv-vaccine-and-mab-snapshot\/. 2021."},{"key":"10.1016\/j.vaccine.2022.06.034_b0075","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMoa1908380","article-title":"Respiratory syncytial virus vaccination during pregnancy and effects in infants","volume":"383","author":"Madhi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.06.034_b0080","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3389\/fimmu.2020.01282","article-title":"Global perspectives on immunization during pregnancy and priorities for future research and development: an international consensus statement","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0085","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.vaccine.2019.12.056","article-title":"The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: systematic review and meta-analysis","volume":"38","author":"Jarvis","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.034_b0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12879-020-4824-3","article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review","volume":"20","author":"Vygen-Bonnet","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0100","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1086\/322971","article-title":"Influence of maternal antibodies on neonatal immunization against respiratory viruses","volume":"33","author":"Crowe","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008088","article-title":"The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya","volume":"4","author":"Ochola","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.06.034_b0110","first-page":"59","article-title":"Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-foetal transfer of measles and tetanus antibodies in a rural west African population","volume":"19","author":"Okoko","year":"2001","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.vaccine.2022.06.034_b0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1128\/cdli.3.4.477-479.1996","article-title":"Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States","volume":"3","author":"Suara","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0120","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1097\/INF.0000000000002364","article-title":"Hypergammaglobulinemia and impaired transplacental transfer of respiratory syncytial virus antibody in Papua new Guinea","volume":"38","author":"Atwell","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2022.06.034_b0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/infdis\/jiv401","article-title":"Impact of placental malaria and hypergammaglobulinemia on transplacental transfer of respiratory syncytial virus antibody in Papua New Guinea","volume":"213","author":"Atwell","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0130","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/infdis\/jiu316","article-title":"Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh","volume":"210","author":"Chu","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcv.2017.08.017","article-title":"Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal","volume":"95","author":"Chu","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4049\/immunohorizons.1700057","article-title":"The impact of IgG transplacental transfer on early life immunity","volume":"2","author":"Fouda","year":"2018","journal-title":"Immunohorizons"},{"key":"10.1016\/j.vaccine.2022.06.034_b0145","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3389\/fimmu.2017.01294","article-title":"Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy","volume":"8","author":"Wilcox","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008303","article-title":"Maternal gatekeepers: how maternal antibody Fc characteristics influence passive transfer and infant protection","volume":"16","author":"Langel","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2022.06.034_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007161","article-title":"Noncanonical placental Fc receptors: what is their role in modulating transplacental transfer of maternal IgG?","volume":"14","author":"Martinez","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2022.06.034_b0160","doi-asserted-by":"crossref","unstructured":"de Taeye SWR T, Vidarsson G, 2019. The Ligands for Human IgG and Their Effector Functions. Antibodies. 2019, 8.","DOI":"10.3390\/antib8020030"},{"key":"10.1016\/j.vaccine.2022.06.034_b0165","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ncomms1608","article-title":"Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential","volume":"2","author":"Stapleton","year":"2011","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2022.06.034_b0170","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/S0264-410X(03)00334-7","article-title":"Placental transport of immunoglobulin G","volume":"21","author":"Simister","year":"2003","journal-title":"Vaccine"},{"issue":"202\u201315","key":"10.1016\/j.vaccine.2022.06.034_b0175","article-title":"Fc glycan-mediated regulation of placental antibody transfer","volume":"178","author":"Jennewein","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2022.06.034_b0180","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3389\/fimmu.2020.01920","article-title":"Update on transplacental transfer of IgG subclasses: impact of maternal and fetal factors","volume":"11","author":"Clements","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/19420862.2018.1433974","article-title":"Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo","volume":"10","author":"Jacobino","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.vaccine.2022.06.034_b0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/rmv.1773","article-title":"Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity","volume":"24","author":"Jans","year":"2014","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0195","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1128\/jcm.24.2.304-306.1986","article-title":"Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection","volume":"24","author":"Wagner","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0200","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/jcm.27.3.589-592.1989","article-title":"Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections","volume":"27","author":"Wagner","year":"1989","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0205","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S1473-3099(17)30229-3","article-title":"Maternal immunisation: collaborating with mother nature","volume":"17","author":"Marchant","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"628\u201342","key":"10.1016\/j.vaccine.2022.06.034_b0210","article-title":"Compromised SARS-CoV-2-specific placental antibody transfer","volume":"184","author":"Atyeo","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2022.06.034_b0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/QCO.0000000000000646","article-title":"Antibody glycosylation in pregnancy and in newborns: biological roles and implications","volume":"33","author":"Rice","year":"2020","journal-title":"Curr Opin Infect Diseases"},{"issue":"190\u2013201","key":"10.1016\/j.vaccine.2022.06.034_b0220","article-title":"Fc characteristics mediate selective placental transfer of IgG in HIV-infected women","volume":"178","author":"Martinez","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2022.06.034_b0225","doi-asserted-by":"crossref","first-page":"12943","DOI":"10.1073\/pnas.2004325117","article-title":"FcRn, but not FcgammaRs, drives maternal-fetal transplacental transport of human IgG antibodies","volume":"117","author":"Borghi","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2022.06.034_b0230","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10719-012-9381-6","article-title":"Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G","volume":"30","author":"Einarsdottir","year":"2013","journal-title":"Glycoconj J"},{"key":"10.1016\/j.vaccine.2022.06.034_b0235","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QCO.0000000000000372","article-title":"Placental transfer of antibody and its relationship to vaccination in pregnancy","volume":"30","author":"Calvert","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cid\/ciy1071","article-title":"Impaired transplacental transfer of respiratory syncytial virus-neutralizing antibodies in human immunodeficiency virus-infected versus -uninfected pregnant women","volume":"69","author":"Jallow","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0245","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/322808","article-title":"The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population","volume":"184","author":"Okoko","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0250","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-3156.2001.00741.x","article-title":"The influence of prematurity and low birthweight on transplacental antibody transfer in a rural West African population","volume":"6","author":"Okoko","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2022.06.034_b0255","doi-asserted-by":"crossref","unstructured":"Yildiz M, Kara M, Sutcu M, Mese S, Demircili ME, Sivrikoz TS, et al. Evaluation of respiratory syncytial virus IgG antibody dynamics in mother-infant pairs cohort. Eur J Clin Microbiol Infect Diseases: Offi Publicat Eur Soc Clin Microbiol. 2020;39:1279-86.","DOI":"10.1007\/s10096-020-03841-8"},{"key":"10.1016\/j.vaccine.2022.06.034_b0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.earlhumdev.2010.11.003","article-title":"Transplacental transport of IgG antibodies to preterm infants: a review of the literature","volume":"87","author":"van den Berg","year":"2011","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.vaccine.2022.06.034_b0265","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0264-410X(01)00418-2","article-title":"Materno-foetal transfer of H. influenzae and pneumococcal antibodies is influenced by prematurity and low birth weight: implications for conjugate vaccine trials","volume":"20","author":"Okoko","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.034_b0270","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/jpids\/piaa040","article-title":"Transplacental respiratory syncytial virus and influenza virus antibody transfer in alaska native and seattle mother-infant Pairs","volume":"10","author":"Chu","year":"2021","journal-title":"J Pediat Infect Diseases Soc"},{"key":"10.1016\/j.vaccine.2022.06.034_b0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.12688\/wellcomeopenres.17636.2","article-title":"Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya","volume":"7","author":"Nyiro","year":"2022","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.vaccine.2022.06.034_b0280","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-019-0392-8","article-title":"The repertoire of maternal anti-viral antibodies in human newborns","volume":"25","author":"Pou","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2022.06.034_b0285","first-page":"317","article-title":"Transplacental antibody transfer and neonatal immunity","volume":"58","author":"de Moraes-Pinto","year":"1997","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.vaccine.2022.06.034_b0290","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/infdis\/173.5.1077","article-title":"Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection","volume":"173","author":"de Moraes-Pinto","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0295","doi-asserted-by":"crossref","first-page":"F202","DOI":"10.1136\/fn.79.3.F202","article-title":"Placental antibody transfer: influence of maternal HIV infection and placental malaria","volume":"79","author":"de Moraes-Pinto","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.vaccine.2022.06.034_b0300","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1086\/429963","article-title":"Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples","volume":"191","author":"Scott","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0305","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1086\/519845","article-title":"Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya","volume":"196","author":"Cumberland","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0310","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(94)90991-1","article-title":"Reduced transfer of tetanus antibodies with placental malaria","volume":"343","author":"Brair","year":"1994","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.vaccine.2022.06.034_b0315","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/00034983.1999.11813407","article-title":"The influence of prematurity and low birthweight on transplacental antibody transfer in Sri Lanka","volume":"93","author":"Wesumperuma","year":"1999","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0320","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/cid\/cix1088","article-title":"Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women: A Longitudinal Cohort Study","volume":"66","author":"Madhi","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094714","article-title":"Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants","volume":"9","author":"van den Berg","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.06.034_b0330","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/INF.0b013e3181dc4f77","article-title":"Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants","volume":"29","author":"van den Berg","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2022.06.034_b0335","doi-asserted-by":"crossref","first-page":"687","DOI":"10.6061\/clinics\/2016(12)02","article-title":"Passive acquisition of anti-Staphylococcus aureus antibodies by newborns via transplacental transfer and breastfeeding, regardless of maternal colonization","volume":"71","author":"Nadaf","year":"2016","journal-title":"Clinics (Sao Paulo, Brazil)"},{"key":"10.1016\/j.vaccine.2022.06.034_b0340","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","article-title":"Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies","volume":"5","author":"Niewiesk","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0345","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fimmu.2016.00338","article-title":"Transfer of maternal antimicrobial immunity to HIV-exposed uninfected newborns","volume":"7","author":"Abu-Raya","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.614246","article-title":"Reduced placental transfer of antibodies against a wide range of microbial and vaccine antigens in HIV-infected women in mozambique","volume":"12","author":"Alonso","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0355","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.vaccine.2014.01.033","article-title":"Maternal pneumococcal capsular IgG antibodies and transplacental transfer are low in South Asian HIV-infected mother-infant pairs","volume":"32","author":"Gupta","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.034_b0360","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jpids\/piz056","article-title":"Placental transfer of respiratory syncytial virus antibody among HIV-exposed, uninfected infants","volume":"9","author":"Patel","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2022.06.034_b0365","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/QAD.0000000000001393","article-title":"Excess respiratory viral infections and low antibody responses among HIV-exposed, uninfected infants","volume":"31","author":"Weinberg","year":"2017","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.vaccine.2022.06.034_b0370","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw092","article-title":"Maternal human immunodeficiency virus-associated hypergammaglobulinemia reduces transplacental transfer of immunoglobulin G to plasmodium falciparum antigens in cameroonian neonates","author":"Babakhanyan","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"40","key":"10.1016\/j.vaccine.2022.06.034_b0375","first-page":"494","article-title":"High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody","volume":"2005","author":"Farquhar","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2022.06.034_b0380","doi-asserted-by":"crossref","first-page":"7439605","DOI":"10.1155\/2016\/7439605","article-title":"Neonatal tetanus immunity in Nigeria: The effect of HIV infection on serum levels and transplacental transfer of antibodies","volume":"2016","author":"Bashir","year":"2016","journal-title":"J Trop Med"},{"key":"10.1016\/j.vaccine.2022.06.034_b0385","first-page":"415","article-title":"Reduced transplacental transfer of group b streptococcus surface protein antibodies in HIV-infected mother-newborn dyads","volume":"215","author":"Dzanibe","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0390","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.vaccine.2014.12.025","article-title":"Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection","volume":"33","author":"Le Doare","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.034_b0395","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QAD.0000000000000923","article-title":"Placental transfer of anti-group B Streptococcus immunoglobulin G antibody subclasses from HIV-infected and uninfected women to their uninfected infants","volume":"30","author":"Le Doare","year":"2016","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.vaccine.2022.06.034_b0400","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcv.2017.07.009","article-title":"Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease","volume":"94","author":"Jallow","year":"2017","journal-title":"J Clin Virol: Off Publicat Pan Am Soc Clin Virol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0405","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jama.2011.100","article-title":"Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants","volume":"305","author":"Jones","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.06.034_b0410","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1570162043485068","article-title":"B lymphocyte dysfunctions in HIV infection","volume":"2","author":"De Milito","year":"2004","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.vaccine.2022.06.034_b0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2019.09.001","article-title":"IgG abnormalities in HIV-positive Malawian women initiating antiretroviral therapy during pregnancy persist after 24 months of treatment","volume":"88","author":"Baroncelli","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40794-016-0044-7","article-title":"Vaccination of HIV-infected pregnant women: implications for protection of their young infants","volume":"3","author":"Dangor","year":"2017","journal-title":"Trop Diseases Travel Medicine Vacc"},{"key":"10.1016\/j.vaccine.2022.06.034_b0425","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/infdis\/jiv339","article-title":"Kinetics of hemagglutination-inhibiting antibodies following maternal influenza vaccination among mothers with and those without HIV infection and their infants","volume":"212","author":"Nunes","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0430","doi-asserted-by":"crossref","unstructured":"Ho A, Mapurisa G, Madanitsa M, Kalilani-Phiri L, Kamiza S, Makanani B, et al. Impact of Maternal HIV Infection and Placental Malaria on the Transplacental Transfer of Influenza Antibodies in Mother-Infant Pairs in Malawi, 2013-2014. Open forum infectious diseases. 2019;6:ofz383.","DOI":"10.1093\/ofid\/ofz383"},{"key":"10.1016\/j.vaccine.2022.06.034_b0435","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4faa7351-837e-4531-a513-0ea80277017f","article-title":"Does malaria affect placental development? Evidence from in vitro models","volume":"8","author":"Umbers","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.06.034_b0440","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1473-3099(07)70022-1","article-title":"Malaria in pregnancy: pathogenesis and immunity","volume":"7","author":"Rogerson","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0445","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00006454-200007000-00010","article-title":"Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children","volume":"19","author":"Hartter","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2022.06.034_b0450","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1590\/S1413-86702008000100011","article-title":"Placental transfer of Haemophilus influenzae type b antibodies in malnourished pregnant women","volume":"12","author":"Cavalcante","year":"2008","journal-title":"Braz J Infect Diseases: Off Publicat the Braz Soc Infect Diseas"},{"key":"10.1016\/j.vaccine.2022.06.034_b0455","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tjog.2019.05.004","article-title":"Effects of maternal smoking on human placental vascularization: a systematic review","volume":"58","author":"Pintican","year":"2019","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2005.02.003","article-title":"The adverse effects of maternal smoking on the human placenta: a review","author":"Zdravkovic","year":"2005","journal-title":"Placenta"},{"key":"10.1016\/j.vaccine.2022.06.034_b0465","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/928187","article-title":"Transfer of maternal immunity to newborns of diabetic mothers","volume":"2012","author":"Franca","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0470","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/sji.12258","article-title":"Placental transfer of IgG antibodies specific to Klebsiella and Pseudomonas LPS and to group B Streptococcus in twin pregnancies","volume":"81","author":"Stach","year":"2015","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0475","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/sji.12466","article-title":"Maternal-foetal diabetes modifies neonatal Fc receptor expression on human leucocytes","volume":"84","author":"de Souza","year":"2016","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2022.06.034_b0480","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/infdis\/jiz390","article-title":"Safety and immunogenicity of a respiratory syncytial virus fusion (F) protein nanoparticle vaccine in healthy third-trimester pregnant women and their infants","volume":"220","author":"Munoz","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.034_b0485","doi-asserted-by":"crossref","DOI":"10.1289\/EHP318","article-title":"Humoral immunity in arsenic-exposed children in rural bangladesh: total immunoglobulins and vaccine-specific antibodies","volume":"125","author":"Raqib","year":"2017","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.vaccine.2022.06.034_b0490","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ped.12396","article-title":"Arsenic exposure increases maternal but not cord serum IgG in Bangladesh","volume":"57","author":"Ser","year":"2015","journal-title":"Pediatr Int"},{"key":"10.1016\/j.vaccine.2022.06.034_b0495","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/INF.0000000000001749","article-title":"Higher transplacental pathogen-specific antibody transfer among pregnant women randomized to triple antiretroviral treatment versus short course zidovudine","volume":"37","author":"Bosire","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2022.06.034_b0500","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.vaccine.2015.05.093","article-title":"WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23\u201324 March 2015","volume":"34","author":"Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VS, Group WRVCE","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:15:08Z","timestamp":1759403708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22007836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":100,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0264410X22007836"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}